IN THE SPOTLIGHT

AstraZeneca's Drug Approved for Treating Limited-Stage Small Cell Lung Cancer in Europe

AstraZeneca's Drug Approved for Treating Limited-Stage Small Cell Lung Cancer in Europe

Tarlatamab Demonstrates Positive Benefit-Risk Profile in SCLC

Tarlatamab Demonstrates Positive Benefit-Risk Profile in SCLC

Small Cell Lung Cancer in 2024: Treatment Advances

Small Cell Lung Cancer in 2024: Treatment Advances

Continued Atezolizumab Shows Durable Benefit in Pretreated ES-SCLC

Continued Atezolizumab Shows Durable Benefit in Pretreated ES-SCLC

Top advances of the year: Small cell lung cancer

Top advances of the year: Small cell lung cancer

Basic science and translational implications of current knowledge on neuroendocrine tumors

Basic science and translational implications of current knowledge on neuroendocrine tumors

'Juuuust a bit outside!' Uecker's acting and broadcasting ability came together in 'Major League'

'Juuuust a bit outside!' Uecker's acting and broadcasting ability came together in 'Major League'

The Role of Molecular Profiling in Small Cell Lung Cancer

The Role of Molecular Profiling in Small Cell Lung Cancer

When should lung cancer be treated with immunotherapy?

When should lung cancer be treated with immunotherapy?